Coultreon Biopharma

Private

LeuvenHealthcare & Life Scienceshttps://www.coultreon.com/

Last Round

Series A

Apr 28, 2026

Total Funding Raised

$148.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Coultreon Biopharma is a biotechnology company that develops therapies targeting clinically-validated pathways across immunology and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Application

Keywords

autoimmune diseasesSIK3 inhibitorprecision medicinesmall molecule drugsclinical-stage biotechimmunologysalt-inducible kinaseoral therapypsoriasis treatmentulcerative colitis treatmentdrug discoverydrug developmentAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coultreon Biopharma Comps

Public and private peers based on sector, stage, and business model.

Coultreon Biopharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Coultreon Biopharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 28, 2026
Seed	Apr 1, 2025

View all Funding Rounds

Coultreon Biopharma Investors

Notable investors and investment history

Coultreon Biopharma investors
Investor	Rounds
Balyasny Asset Management L.P.	Series A
Finchley Healthcare Ventures	Series A
Forbion	Series A
Novo Holdings	Series A
Galapagos NV	Series A, Seed
Longwood Fund	Series A
Samsara BioCapital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 28, 2026
$125M round led by Novo Holdings and Sofinnova Investments
Apr 1, 2025
$23M round led by Galapagos NV.

View all signals

Coultreon Biopharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Coultreon Biopharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coultreon Biopharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeuven

Year Founded2025

Last FundingApr 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.